Table 1 Study population and characteristics of lesion.

From: MicroRNA expression profile of human advanced coronary atherosclerotic plaques

Age/Gender

BMI (kg/gm)

Risk factors

Type of stenosis

Location of lesion

Number of sections per plaque

Macrophages (CD68) in the shoulder region

1

80/W

22.43

H

deNovo

RCx

1

++

2

73/W

25.16

H

deNovo

RCA

3

+

3

73/M

25.26

H

deNovo

LAD

2

++

4

54/M

27.78

F

deNovo

LAD

2

++

5

68/M

33.02

O

deNovo

LAD

1

+

6

76/M

33.17

DM II, H, O

restenosis

LAD

1

+

7

62/M

30.61

DM II, H, O

deNovo

LAD

2

++

8

61/M

27.76

H, O

restenosis

LAD

3

+

9

65/M

27.14

N, O

deNovo

LAD

1

++

10

65/M

28.08

H, O, N

deNovo

LAD

3

+

11

41/W

18.52

H, DM L, F

deNovo

LAD

3

++

12

47/M

30.30

H, O

deNovo

LAD

1

++

  1. LAD, left anterior descending; RCx, Ramus circumflexus; RCA, right coronary artery; BMI, Body-Mass-Index, DM, diabetes mellitus typ I and II; H, hypertension; L, hyperlipoproteinaemia; F, family disposition; N, nicotine; O, obesity; M, man; W, woman.
  2. 0 = no detectable staining; + = weak positive staining; ++ = strong positive staining.